Home/Filings/4/0001415889-24-002522
4//SEC Filing

Goncalves Joana 4

Accession 0001415889-24-002522

CIK 0001346830other

Filed

Feb 4, 7:00 PM ET

Accepted

Feb 5, 4:30 PM ET

Size

5.3 KB

Accession

0001415889-24-002522

Insider Transaction Report

Form 4
Period: 2024-02-01
Goncalves Joana
Chief Medical Officer
Transactions
  • Award

    Common Stock

    2024-02-01+13,50067,181 total
Footnotes (1)
  • [F1]Represents the number of shares that vested under a performance-based restricted stock unit award (the "Award") granted on March 1, 2023 based on the Issuer's satisfaction of certain performance criteria of the Award. In light of the performance-based vesting conditions of the Award, such shares were not reportable under Section 16 until vesting was determined. On February 1, 2024, the Compensation Committee of the Issuer's Board of Directors certified a 50% level of achievement against the Award's performance goals.

Issuer

Cara Therapeutics, Inc.

CIK 0001346830

Entity typeother

Related Parties

1
  • filerCIK 0001756991

Filing Metadata

Form type
4
Filed
Feb 4, 7:00 PM ET
Accepted
Feb 5, 4:30 PM ET
Size
5.3 KB